Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Lactobacillus paracasei feeding improves immune control of influenza infection in mice.

Belkacem N, Serafini N, Wheeler R, Derrien M, Boucinha L, Couesnon A, Cerf-Bensussan N, Gomperts Boneca I, Di Santo JP, Taha MK, Bourdet-Sicard R.

PLoS One. 2017 Sep 20;12(9):e0184976. doi: 10.1371/journal.pone.0184976. eCollection 2017.

2.

Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1.

Nita-Lazar M, Banerjee A, Feng C, Vasta GR.

Mol Immunol. 2015 Dec;68(2 Pt A):194-202. doi: 10.1016/j.molimm.2015.08.005. Epub 2015 Sep 6.

3.

The association of meningococcal disease with influenza in the United States, 1989-2009.

Jacobs JH, Viboud C, Tchetgen ET, Schwartz J, Steiner C, Simonsen L, Lipsitch M.

PLoS One. 2014 Sep 29;9(9):e107486. doi: 10.1371/journal.pone.0107486. eCollection 2014.

4.

Meningococcal disease and the complement system.

Lewis LA, Ram S.

Virulence. 2014 Jan 1;5(1):98-126. doi: 10.4161/viru.26515. Epub 2013 Oct 8. Review.

5.

In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa.

Johswich KO, McCaw SE, Islam E, Sintsova A, Gu A, Shively JE, Gray-Owen SD.

PLoS Pathog. 2013;9(7):e1003509. doi: 10.1371/journal.ppat.1003509. Epub 2013 Jul 25.

6.

Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process.

Mattos IB, Alves DA, Hollanda LM, Ceragiogli HJ, Baranauskas V, Lancellotti M.

J Nanobiotechnology. 2011 Nov 16;9:53. doi: 10.1186/1477-3155-9-53.

7.

Do multiple concurrent infections in African children cause irreversible immunological damage?

Glennie SJ, Nyirenda M, Williams NA, Heyderman RS.

Immunology. 2012 Feb;135(2):125-32. doi: 10.1111/j.1365-2567.2011.03523.x. Review.

8.

Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin.

Szatanik M, Hong E, Ruckly C, Ledroit M, Giorgini D, Jopek K, Nicola MA, Deghmane AE, Taha MK.

PLoS One. 2011;6(7):e22210. doi: 10.1371/journal.pone.0022210. Epub 2011 Jul 21.

9.

Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.

Hollanda LM, Cury GC, Pereira RF, Ferreira GA, Sousa A, Sousa EM, Lancellotti M.

J Nanobiotechnology. 2011 Jul 25;9:28. doi: 10.1186/1477-3155-9-28.

10.

A mouse model of lethal synergism between influenza virus and Haemophilus influenzae.

Lee LN, Dias P, Han D, Yoon S, Shea A, Zakharov V, Parham D, Sarawar SR.

Am J Pathol. 2010 Feb;176(2):800-11. doi: 10.2353/ajpath.2010.090596. Epub 2009 Dec 30.

11.

Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules.

Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, van der Werf S, Alonso JM, Naffakh N, Taha MK.

Infect Immun. 2009 Sep;77(9):3588-95. doi: 10.1128/IAI.00155-09. Epub 2009 Jun 15.

12.

The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice.

Colicchio R, Ricci S, Lamberti F, Pagliarulo C, Pagliuca C, Braione V, Braccini T, TalĂ  A, Montanaro D, Tripodi S, Cintorino M, Troncone G, Bucci C, Pozzi G, Bruni CB, Alifano P, Salvatore P.

Infect Immun. 2009 Sep;77(9):3578-87. doi: 10.1128/IAI.01424-08. Epub 2009 Jun 15.

13.

Animal models for the study of influenza pathogenesis and therapy.

Barnard DL.

Antiviral Res. 2009 May;82(2):A110-22. doi: 10.1016/j.antiviral.2008.12.014. Epub 2009 Jan 25. Review.

14.
15.

Respiratory infections: do we ever recover?

Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E, Wales J, Wissinger EL, Hussell T.

Proc Am Thorac Soc. 2007 Dec;4(8):618-25. Review.

16.

The impact of successive infections on the lung microenvironment.

Didierlaurent A, Goulding J, Hussell T.

Immunology. 2007 Dec;122(4):457-65. Review.

17.

Transgenic mice expressing human transferrin as a model for meningococcal infection.

Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, Guillou F, Alonso JM, Taha MK.

Infect Immun. 2007 Dec;75(12):5609-14. Epub 2007 Sep 24.

18.
19.

Carriage of Neisseria meningitidis serogroup W135 ST-2881.

Boisier P, Nicolas P, Djibo S, Hamidou AA, Tenebray B, Borrow R, Chanteau S.

Emerg Infect Dis. 2006 Sep;12(9):1421-3.

20.

Supplemental Content

Support Center